日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The strong clinical interaction between bupropion and CYP2D6 is primarily mediated through bupropion metabolites and their stereoisomers: A paradigm for evaluating metabolites in drug-drug interaction risk

安非他酮与CYP2D6之间强烈的临床相互作用主要通过安非他酮代谢物及其立体异构体介导:这是评估药物相互作用风险中代谢物的范例。

Tanaudommongkon, Irin; Rashidian, Amir; Gufford, Brandon T; Lu, Jessica Bo Li; Desta, Zeruesenay

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers

(2R,6R)-羟基去甲氯胺酮在健康志愿者中的安全性、耐受性、药代动力学和药效学的I期评估

Raja, Shruti M; Guptill, Jeffrey T; Mack, Michelle; Peterson, Marni; Byard, Stephen; Twieg, Robert; Jordan, Lynn; Rich, Natalie; Castledine, Richard; Bourne, Samuel; Wilmshurst, Martin; Oxendine, Sarah; Avula, Satya G C; Zuleta, Helen; Quigley, Paul; Lawson, Sheila; McQuaker, Stephen J; Ahmadkhaniha, Reza; Appelbaum, Lawrence G; Kowalski, Kevin; Barksdale, Chineta T; Gufford, Brandon T; Awan, Asaad; Sancho, Alfredo R; Moore, Max C; Berrada, Karim; Cogan, Gregory B; DeLaRosa, Jesse; Radcliffe, Jeanne; Pao, Maryland; Kennedy, Michelle; Lawrence, Quentin; Goldfeder, Lisa; Amanfo, Leslie; Zanos, Panos; Gilbert, Jessica R; Morris, Patrick J; Moaddel, Ruin; Gould, Todd D; Zarate, Carlos A Jr; Thomas, Craig J

The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial

INGENIOUS试验:药物基因组学检测对实用性临床试验中不良事件的影响

Eadon, Michael T; Rosenman, Marc B; Zhang, Pengyue; Fulton, Cathy R; Callaghan, John T; Holmes, Ann M; Levy, Kenneth D; Gupta, Samir K; Haas, David M; Vuppalanchi, Raj; Benson, Eric A; Kreutz, Rolf P; Tillman, Emma M; Shugg, Tyler; Pierson, Rebecca C; Gufford, Brandon T; Pratt, Victoria M; Zang, Yong; Desta, Zeruesenay; Dexter, Paul R; Skaar, Todd C

Influence of CYP2B6 Pharmacogenetics on Stereoselective Inhibition and Induction of Bupropion Metabolism by Efavirenz in Healthy Volunteers

CYP2B6 药物遗传学对健康志愿者中依法韦仑立体选择性抑制和诱导安非他酮代谢的影响

Brandon T Gufford, Ingrid F Metzger, Nadia O Bamfo, Eric A Benson, Andrea R Masters, Jessica Bo Li Lu, Zeruesenay Desta

Mass balance and pharmacokinetics of an oral dose of (14) C-napabucasin in healthy adult male subjects

健康成年男性受试者口服(14)C-纳帕布卡辛后的质量平衡和药代动力学

Dai, Xiaoshu; Karol, Michael D; Hitron, Matthew; Hard, Marjie L; Blanchard, John Evan; Eraut, Nicola C J E; Rich, Natalie; Gufford, Brandon T

Randomized, Double-Blind, Controlled Study to Evaluate Safety and Pharmacokinetics of Single Ascending Doses of ASP5354, an Investigational Imaging Product, in Healthy Adult Volunteers

一项随机、双盲、对照研究,旨在评估在研影像产品 ASP5354 单次递增剂量在健康成年志愿者中的安全性和药代动力学。

Murase, Tosei; Takizawa, Masaomi; Galitz, Lawrence; Flach, Stephen; Murray, Valene; Gufford, Brandon; Suwa, Akira

Influence of Uridine Diphosphate Glucuronosyltransferase Family 1 Member A1 and Solute Carrier Organic Anion Transporter Family 1 Member B1 Polymorphisms and Efavirenz on Bilirubin Disposition in Healthy Volunteers

尿苷二磷酸葡萄糖醛酸转移酶家族 1 成员 A1 和溶质载体有机阴离子转运蛋白家族 1 成员 B1 多态性及依非韦伦对健康志愿者胆红素代谢的影响

Kimberly S Collins,Ingrid F Metzger,Brandon T Gufford,Jessica B Lu,Elizabeth B Medeiros,Victoria M Pratt,Todd C Skaar,Zeruesenay Desta

A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: From Chemical Characterization to Clinical Studies

用于药代动力学天然产物-药物相互作用的新数据存储库:从化学表征到临床研究

Birer-Williams, Caroline; Gufford, Brandon T; Chou, Eric; Alilio, Marijanel; VanAlstine, Sidney; Morley, Rachael E; McCune, Jeannine S; Paine, Mary F; Boyce, Richard D

Probenecid-Boosted Tenofovir: A Physiologically-Based Pharmacokinetic Model-Informed Strategy for On-Demand HIV Preexposure Prophylaxis

丙磺舒增强替诺福韦:基于生理药代动力学模型的按需HIV暴露前预防策略

Liu, Stephanie N; Desta, Zeruesenay; Gufford, Brandon T

Mechanistic Assessment of Extrahepatic Contributions to Glucuronidation of Integrase Strand Transfer Inhibitors

整合酶链转移抑制剂葡萄糖醛酸化的肝外贡献机制评估

Stephanie N Liu, Jessica Bo Li Lu, Christy J W Watson, Philip Lazarus, Zeruesenay Desta, Brandon T Gufford